Murray, K., Rogers, R., Selvey, L., Selleck, P., Hyatt, A., Gould, A., Gleeson, L., Hooper, P. & Westbury, H. (1995). A novel morbillivirus pneumonia of horses and its transmission to humans. Emerg Infect Dis 1, 31-3. Na, B. K., Lee, J. S., Shin, G. C., Shin, J. M., Lee, J. Y., Chung, J. K., Ha, D. R., Lee, J. K., Ma, S. H., Cho, H. W., Kang, C. & Kim, W. J. (2001). Sequence analysis of hemagglutinin and nucleoprotein genes of measles viruses isolated in Korea during the 2000 epidemic. Virus Res 81, 143-9. Naniche, D., Varior-Krishnan, G., Cervoni, F., Wild, T. F., Rossi, B., Rabourdin-Combe, C. & Gerlier, D. (1993a). Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67, 6025-32. Naniche, D., Wild, T. F., Rabourdin-Combe, C. & Gerlier, D. (1992). A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol 73, 2617-24. Naniche, D., Wild, T. F., Rabourdin-Combe, C. & Gerlier, D. (1993b). Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol 74, 1073-9. Naniche, D., Reed, S. I. & Oldstone, M. B. (1999). Cell cycle arrest during measles virus infection: a G0-like block leads to suppression of retinoblastoma protein expression. J Virol 73, 1894-901. Naniche, D., Yeh, A., Eto, D., Manchester, M., Friedman, R. M. & Oldstone, M. B. (2000). Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. J Virol 74, 7478-84. Ndikuyeze, A., Munoz, A., Stewart, J., Modlin, J., Heymann, D., Herrmann, K. L. & Polk, B. F. (1988). Immunogenicity and safety of measles vaccine in ill African children. Int J Epidemiol 17, 448-55. Nichol, K. L. (2001). Live attenuated influenza virus vaccines: new options for the prevention of influenza. Vaccine 19, 4373-7. Nielsen, L., Blixenkrone-Moller, M., Thylstrup, M., Hansen, N. J. & Bolt, G. (2001). Adaptation of wild-type measles virus to CD46 receptor usage. Arch Virol 146, 197- 208. Nigatu, W., Jin, L., Cohen, B. J., Nokes, D. J., Etana, M., Cutts, F. T. & Brown, D. W. (2001). Measles virus strains circulating in Ethiopia in 1998-1999: molecular characterisation using oral fluid samples and identification of a new genotype. J Med Virol 65, 373-80. 161
Norrby, E., Enders-Ruckles, G. & Meulen, V. t. (1975). Difference in appearence of antibidies to structural components of measles virus after immunization with innactivated and live virus. J Infect Dis 132, 262-9. Nur, Y., Groen, J., Yusuf, M. & Osterhaus, A. (1999). IgM antibodies in hospitalized children with febrile illness during an inter-epidemic period of measles in Somalia. J Clin Virol 12, 21-25. NVAC, The National Vaccine Advisory Commitee (1991). The measles epidemic: The problems, barriers and recommendations. JAMA 266, 1547-1552. Ogra, P. L., Fishaut, M. & Gallagher, M. R. (1980). Viral vaccination via the mucosal routes. Rev Infect Dis 2, 352-69. Ogura, H., Sato, H., Kamiya, S. & Nakamura, S. (1991). Glycosylation of measles virus haemagglutinin protein in infected cells. J Gen Virol 72, 2679-84. Okoko, J. B., Wesumperuma, H. L. & Hart, C. A. (2001). The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population. Trop Med Int Health 6, 529-34. Ono, N., Tatsuo, H., Hidaka, Y., Aoki, T., Minagawa, H. & Yanagi, Y. (2001a). Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75, 4399-401. Ono, N., Tatsuo, H., Tanaka, K., Minagawa, H. & Yanagi, Y. (2001b). V domain of human S<strong>LA</strong>M (CDw150) is essential for its function as a measles virus receptor. J Virol 75, 1594-600. Onorato, I. M., Jones, T. S. & Orenstein, W. A. (1988). Immunising children infected with HIV. Lancet 1, 354-5. Orenstein, W. A., Bernier, R. H. & Hinman, A. R. (1988). Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 10, 212-41. Outlaw, M. C. & Pringle, C. R. (1995). Sequence variation within an outbreak of measles virus in the Coventry area during spring/summer 1993. Virus Res 39, 3-11. Outlaw, M. C., Jaye, A., Whittle, H. C. & Pringle, C. R. (1997). Clustering of haemagglutinin gene sequences of measles viruses isolated in the Gambia. Virus Res 48, 125-31. Oxtoby, M., Ryder, R., Mvula, M. & al., e. (1989). Patterns of immunity to measles among african children infected with the human immunodeficiency virus. In: Abstracs of the Epidemic Intelligence Service Conference, Atlanta, USA, April 1989. Atlanta: US Center for Disease Contol. 162
- Page 1 and 2:
UNIVERSITE JOSEPH FOURIER-GRENOBLE
- Page 3 and 4:
Je remercie le Dr Florence PRADEL e
- Page 5 and 6:
II.3 2. Les nouveaux vaccins……
- Page 7 and 8:
VI.3. La rougeole au Cameroun : Etu
- Page 9 and 10:
CHAPITRE I : LE VIRUS DE LA ROUGEOL
- Page 11 and 12:
I.Le virus de la rougeole 2. Classi
- Page 13 and 14:
I.Le virus de la rougeole 3. Struct
- Page 15 and 16:
I.Le virus de la rougeole 4. Struct
- Page 17 and 18:
I.Le virus de la rougeole 4. Struct
- Page 19 and 20:
I.Le virus de la rougeole 5. Cycle
- Page 21 and 22:
I.Le virus de la rougeole 5. Cycle
- Page 23 and 24:
Récepteur cellulaire Etat natif H
- Page 25 and 26:
I.Le virus de la rougeole 6. Pathol
- Page 27 and 28:
I.Le virus de la rougeole 6. Pathol
- Page 29 and 30:
I.Le virus de la rougeole 6. Pathol
- Page 31 and 32:
I.Le virus de la rougeole 6. Pathol
- Page 33 and 34:
II. La vaccination 1. Les vaccins i
- Page 35 and 36:
II. La vaccination 2. Les vaccins v
- Page 37 and 38:
Figure 6 : Souches vaccinales utili
- Page 39 and 40:
II. La vaccination 3. Les nouvelles
- Page 41 and 42:
II. La vaccination 3. Les nouvelles
- Page 43 and 44:
II. La vaccination 4. Position actu
- Page 45 and 46:
CHAPITRE III. ETUDES EPIDEMIOLOGIQU
- Page 47 and 48:
III. Etudes épidémiologiques 1. I
- Page 49 and 50:
III. Etudes épidémiologiques 2. P
- Page 51 and 52:
III. Etudes épidémiologiques 4. R
- Page 53 and 54:
III. Etudes épidémiologiques 4. R
- Page 55 and 56:
III. Etudes épidémiologiques 4. R
- Page 57 and 58:
III. Etudes épidémiologiques 5. P
- Page 59 and 60:
III. Etudes épidémiologiques 5. P
- Page 61 and 62:
IV. Epidémiologie moléculaire du
- Page 63 and 64:
IV. Epidémiologie moléculaire du
- Page 65 and 66:
IV. Epidémiologie moléculaire du
- Page 67 and 68:
IV. Epidémiologie moléculaire du
- Page 69 and 70:
IV. Epidémiologie moléculaire du
- Page 71 and 72:
IV. Epidémiologie moléculaire du
- Page 73 and 74:
V. La rougeole en Afrique 1. La rou
- Page 75 and 76:
V. La rougeole en Afrique 1. La rou
- Page 77 and 78:
V. La rougeole en Afrique 1. La rou
- Page 79 and 80:
Figure 8: Répartition des cas de r
- Page 81 and 82:
V. La rougeole en Afrique 2. La rou
- Page 83 and 84:
VI. Etude des souches Africaines du
- Page 85 and 86:
VI. Etude des souches Africaines du
- Page 87 and 88:
VI. Etude des souches Africaines du
- Page 89 and 90:
VI.1.4. Article 1 : Adaptation des
- Page 91 and 92:
1506 NOTES J. VIROL. FIG. 1. MV inf
- Page 93 and 94:
1508 NOTES J. VIROL. FIG. 3. Flow c
- Page 95 and 96:
VI. Etude des souches Africaines du
- Page 97 and 98:
Figure 9 : Répartition géographiq
- Page 99 and 100:
VI. Etude des souches Africaines du
- Page 101 and 102:
VI. Etude des souches Africaines du
- Page 103 and 104:
Measles virus strains circulating i
- Page 105 and 106:
In 1983, measles viruses isolated i
- Page 107 and 108:
obtained for the two 1983 isolates
- Page 109 and 110:
easons. The available data for meas
- Page 111 and 112:
Malvoisin E, Wild TF. 1990. Contrib
- Page 113 and 114:
106 0.005 100 82 100 86 98 New York
- Page 115 and 116:
Table 1 : African measles strains u
- Page 117 and 118: VI.3. LA ROUGEOLE AU CAMEROUN : ETU
- Page 119 and 120: VI. Etude des souches Africaines du
- Page 121 and 122: VI. Etude des souches Africaines du
- Page 123 and 124: VI. Etude des souches Africaines du
- Page 125 and 126: VI. Etude des souches Africaines du
- Page 127 and 128: VI. Etude des souches Africaines du
- Page 129 and 130: CHAPITRE VII. DISCUSSION 122
- Page 131 and 132: VII. Discussion 1. Interaction viru
- Page 133 and 134: VII. Discussion 1. Interaction viru
- Page 135 and 136: VII. Discussion 2. Epidémiologie C
- Page 137 and 138: VII. Discussion 2. Epidémiologie f
- Page 139 and 140: CHAPITRE VIII. CONCLUSION ET PERSPE
- Page 141 and 142: ANNEXES 134
- Page 143 and 144: Consensus ATATCCATCA TGGGTCTCAA GGT
- Page 145 and 146: Consensus MTEIYDFDKS AWDIKGSIAP IQP
- Page 147 and 148: Consensus ATGTCACCGC AACGAGACCG GAT
- Page 149 and 150: Consensus MSPQRDRINA FYKDNPYPKG SRI
- Page 151 and 152: Consensus MGLKVNVSAI FMAVLLTLQT PAG
- Page 153 and 154: Aaby, P., Bukh, J., Lisse, I. M. &
- Page 155 and 156: Bouteille, M., Fontaine C., Vedrenn
- Page 157 and 158: Davenport, M. P., Quinn, C. L., Chi
- Page 159 and 160: Foege, W. (1971). Measles vaccinati
- Page 161 and 162: Griffin, D. E., Ward, B. J., Jaureg
- Page 163 and 164: Holt, E. A., Moulton, L. H., Siberr
- Page 165 and 166: Kok, P. W., Kenya, P. R. & Ensering
- Page 167: Markowitz, L. E., Albrecht, P., Rho
- Page 171 and 172: Poland, G. A., Jacobson, R. M., Col
- Page 173 and 174: Siber, G. R., Werner, B. G., Halsey
- Page 175 and 176: Truong, A. T., Mulders, M. N., Gaut
- Page 177 and 178: WHO, World Health Organisation, Exp
- Page 179 and 180: TABLE DES ILLUSTRATIONS Figure 1. R
- Page 181: Abstract Despite the availability o